Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation

NCT02522299

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
  • GSK Investigational Site Montreal, Ontario, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View Trial Details
Completed

Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality

NCT02668250

Conditions
Alcohol-Related Disorders, Alcoholism, Arrhythmias, Cardiac, +42 more
Locations
  • CHU Amiens - Picardie Amiens, France
  • CHU CAEN Caen, France
  • Chu Clermont-Ferrand Clermont-Ferrand, France
  • Médipôle Lyon - Villeurbanne Décines-Charpieu, France
View all 29 locations
View Trial Details
Completed

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

NCT00528996

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1205.14.061 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 1205.14.054 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1205.14.042 Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • 1205.14.017 Boehringer Ingelheim Investigational Site La Jolla, California, United States
View all 178 locations
View Trial Details
Completed

An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT02294734

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Erpent, Belgium
  • GSK Investigational Site Aalborg, Denmark
  • GSK Investigational Site Copenhagen, Denmark
View all 17 locations
View Trial Details

Related conditions